Overview

Comparison of the Efficacy and Safety of Risperidone Versus Risperidone Plus Low Dose of Haloperidol in the Treatment of Schizophrenia

Status:
Terminated

Trial end date:
2009-10-01

Target enrollment:

Participant gender:

Summary

The purpose of this study is to compare the efficacy and safety of risperidone and risperidone plus low dose of haloperidol in the acutely schizophrenic patients.

Phase:

Phase 4

Details

Lead Sponsor:

Kaohsiung Kai-Suan Psychiatric Hospital

Treatments:

Haloperidol
Haloperidol decanoate
Risperidone